MISSISSAUGA, Ontario, June 24, 2016 /CNW/ -- Sysmex Canada, Inc., a leading provider of hematology and urinalysis automated diagnostic testing equipment and middleware information systems technology, today announced that it has been granted a non-exclusive agreement with CellaVision® to distribute its full line of digital cell morphology systems in Canada.
In late 2013, Sysmex successfully launched the DI-60 system in the U.S and Canada, with digital cell imaging powered by CellaVision software and integrated into a Sysmex hematology automation line.
This agreement now expands Sysmex Canada's ability to provide CellaVision's DM1200 and DM9600 digital morphology systems. When combined, the Sysmex and CellaVision systems can offer significant clinical and operational benefits for clinical laboratories, including automation of Complete Blood Counts (CBC), enhanced cell identification and automation of the manual cell differential processes. CellaVision's systems also offer remote viewing of samples – cells can be remotely reviewed by pathologists, referring service lines and physicians.
"We're excited to offer CellaVision products to our Canadian customers. This agreement means that Canadian laboratories can now get two of the highest quality hematology systems from one source. said Carl Rocha, general manager, Sysmex Canada, Inc.
About Sysmex Canada, Inc.
Sysmex Canada, Inc. distributes and supports a diverse portfolio of best-in-class, in vitro diagnostic hematology, urinalysis and clinical laboratory products. It is a subsidiary of Sysmex America, Inc. and part of Sysmex Corporation, located in Kobe, Japan. Sysmex is reshaping the healthcare of tomorrow at the clinical laboratory level by transcending the boundaries of diagnostic science and serving as the pulse of reliable, accountable care. For more information about Sysmex, visit www.sysmex.com/ca.
CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in image analysis, artificial intelligence and automated microscopy. Sales are via global partners with support from the mother company in Lund and by the market support organizations in the US, Canada, China and Japan. In 2014 sales were SEK 217 million and sales continue to increase, with a growth target of at least 15 % per year over an economic cycle. CellaVision's registered office is in Lund, Sweden. The share is listed on the Nasdaq OMX Stockholm, Small Cap list. Read more at www.cellavision.com
SOURCE Sysmex Canada, Inc.
For further information: Sysmex Media Relations, Sysmex Canada, Inc., [email protected], 224-543-9500, http://www.sysmex.com/ca